社区药剂师在临床处方检查中的决策模式:基于模拟的研究
Ali Elgebli1, Jason Hall1, Denham L Phipps1
1Division of Pharmacy & Optometry, Faculty of Biology, Medicine & Health, The University of Manchester, Stopford Building, Room 1.183, Oxford Road, Manchester M13 9PT, United Kingdom.
Exploratory research in clinical and social pharmacy
|February 19, 2025
概括
社区药剂师 (CP) 在临床处方检查中使用模式识别和分析思维. 他们的决策不同,突出需要了解影响犹和患者安全的因素.
科学领域:
- 药房实践 在药房实践.
- 认知心理学 认知心理学
- 决策科学 决策科学 决策科学
背景情况:
- 社区药剂师 (CP) 经常对处方进行临床检查,以确保药物的安全性和有效性.
- 这个复杂的过程涉及到许多日常决策,这些决策受到各种实践因素的影响.
- 了解这项关键任务背后的认知过程是必不可少的.
研究的目的:
- 调查社区药剂师 (CP) 在临床处方检查期间使用的认知过程.
- 探索CP在评估处方适当性时使用的决策策略.
主要方法:
- 一项使用有目的抽样的定性研究招募了来自英格兰的CP.
- 参与者通过Zoom采访进行模拟的处方检查,并提供并发的口头表达.
- 对转录的数据进行了演性的专题分析,以基于认可的决策 (RPD) 模型为指导.
主要成果:
- 共有12个CP参与,展示了一个多阶段的决策程序,具有不同的能力来识别和解决问题.
- 药剂师主要使用模式识别,转向非典型情况的分析思维,与RPD模型保持一致.
- 虽然提示处理是一致的,但随后的行动显示出显著的变化和犹.
结论:
- 临床处方检查涉及模式识别和分析思维的结合.
- 药剂师的决策过程和犹存在显著的变化.
- 需要进一步的研究来了解影响这些变化的因素及其对患者安全的影响.
更多相关视频
相关概念视频
Pharmacovigilance
768
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
768
Pharmacokinetic Models: Comparison and Selection Criterion
38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Analysis of Population Pharmacokinetic Data
216
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
216
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
41
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
41
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
Drug Administration and Therapy Phases: Overview
403
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
403


